The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Loss on disposal of property and equipment | - | -115 | -29 | -44 |
| Net loss | -53,156 | 43,700 | 21,567 | -28,235 |
| Depreciation and amortization | 4,174 | 4,066 | 4,029 | 7,178 |
| Amortization and write-down of intangible assets | 5,708 | 798 | 842 | 1,683 |
| Write-down to fair value for asset held for sale (note 8) | - | 1,940 | 922 | 8,313 |
| Reduction in the carrying value of right-of-use assets | 2,488 | 2,149 | 2,116 | 4,077 |
| Non-cash interest expense | 91 | 167 | 69 | 139 |
| Deferred tax benefit | -15,371 | 15,629 | -3,837 | -2,292 |
| Provision recorded for credit losses | -3,959 | 2,810 | 2,287 | 3,116 |
| Adjustment for excess and obsolete inventories | -6,990 | -7,390 | -1,870 | -6,093 |
| Stock-based compensation | 3,636 | 4,324 | 3,065 | 5,909 |
| Accounts receivable | -104,502 | 51,478 | 50,688 | 13,637 |
| Inventories | 8,730 | 2,961 | -938 | 15,892 |
| Prepaid expenses and other current assets and other assets | 1,655 | -3,115 | -9,644 | 12,942 |
| Operating leases | 2,400 | 2,189 | 2,155 | 4,147 |
| Accounts payable | -2,003 | -1,171 | -994 | 1,637 |
| Accrued expenses and other current liabilities | -19,481 | 12,324 | 11,943 | -13,886 |
| Other liabilities | 293 | -1,308 | 1,432 | 34 |
| Net cash provided by (used in) operating activities | 21,127 | 39,420 | 3,079 | -52,808 |
| Purchases of property and equipment | 3,146 | 4,652 | 2,235 | 7,264 |
| Net cash used in investing activities | -3,146 | -4,652 | -2,235 | -7,264 |
| Landlord assets under construction, net of tenant allowance | - | - | 10,039 | - |
| Proceeds from the exercise of stock options | - | 2 | 130 | 25 |
| Landlord assets under construction, net of tenant allowance | 7,322 | 14,461 | - | - |
| Payments of withholding taxes in connection with rsus vesting | 3,051 | 87 | 2 | 1,796 |
| Principal repayments of finance lease obligations | 9,840 | 302 | 296 | 573 |
| Net cash used in financing activities | -20,213 | -4,809 | -10,207 | -2,344 |
| Change in cash, cash equivalents and restricted cash | -2,232 | 29,959 | -9,363 | -62,416 |
| Cash, cash equivalents, and restricted cash, beginning of period | 94,331 | 64,372 | 136,151 | - |
| Cash, cash equivalents, and restricted cash, end of period | 92,099 | 94,331 | 64,372 | - |
Organogenesis Holdings Inc. (ORGO)
Organogenesis Holdings Inc. (ORGO)